Concepts (94)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| MicroRNAs | 7 | 2013 | 2887 | 0.670 |
Why?
|
| Ovarian Neoplasms | 5 | 2012 | 4795 | 0.500 |
Why?
|
| Genes, BRCA1 | 3 | 2010 | 397 | 0.430 |
Why?
|
| Genes, BRCA2 | 2 | 2010 | 322 | 0.380 |
Why?
|
| Allelic Imbalance | 1 | 2010 | 41 | 0.360 |
Why?
|
| DNA, Mitochondrial | 1 | 2009 | 315 | 0.290 |
Why?
|
| Deoxyguanosine | 1 | 2007 | 35 | 0.280 |
Why?
|
| Gene Dosage | 1 | 2009 | 823 | 0.270 |
Why?
|
| Genetic Variation | 3 | 2012 | 2166 | 0.260 |
Why?
|
| Polymorphism, Genetic | 2 | 2008 | 1557 | 0.260 |
Why?
|
| DNA, Neoplasm | 2 | 2007 | 1958 | 0.230 |
Why?
|
| Breast Neoplasms | 6 | 2013 | 16215 | 0.230 |
Why?
|
| Polymorphism, Single Nucleotide | 4 | 2013 | 4644 | 0.220 |
Why?
|
| Gene Expression Profiling | 3 | 2012 | 5149 | 0.190 |
Why?
|
| Precancerous Conditions | 1 | 2006 | 1059 | 0.170 |
Why?
|
| Computational Biology | 1 | 2006 | 1291 | 0.170 |
Why?
|
| Proteomics | 1 | 2006 | 1427 | 0.160 |
Why?
|
| Proteins | 1 | 2006 | 2043 | 0.150 |
Why?
|
| Cytokines | 1 | 2006 | 2825 | 0.140 |
Why?
|
| Genotype | 3 | 2010 | 4252 | 0.130 |
Why?
|
| Lung Neoplasms | 3 | 2007 | 12033 | 0.130 |
Why?
|
| Lung | 1 | 2006 | 3298 | 0.130 |
Why?
|
| Algorithms | 1 | 2006 | 3891 | 0.120 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 4 | 2012 | 2471 | 0.110 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2012 | 5776 | 0.110 |
Why?
|
| Premenopause | 2 | 2012 | 136 | 0.110 |
Why?
|
| Glycemic Index | 1 | 2012 | 29 | 0.100 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 2007 | 5574 | 0.100 |
Why?
|
| Case-Control Studies | 3 | 2010 | 6224 | 0.100 |
Why?
|
| Biomarkers, Tumor | 2 | 2010 | 10708 | 0.100 |
Why?
|
| Cell Line, Tumor | 3 | 2012 | 14849 | 0.090 |
Why?
|
| Female | 13 | 2013 | 148940 | 0.090 |
Why?
|
| Middle Aged | 10 | 2013 | 90352 | 0.090 |
Why?
|
| Family Health | 1 | 2010 | 349 | 0.080 |
Why?
|
| Pilot Projects | 3 | 2012 | 2828 | 0.080 |
Why?
|
| Risk Factors | 3 | 2012 | 17888 | 0.080 |
Why?
|
| Nucleic Acid Conformation | 1 | 2010 | 307 | 0.080 |
Why?
|
| Adult | 9 | 2013 | 82040 | 0.080 |
Why?
|
| DNA Damage | 2 | 2007 | 1989 | 0.080 |
Why?
|
| Postmenopause | 1 | 2009 | 375 | 0.070 |
Why?
|
| Aged | 7 | 2012 | 73333 | 0.070 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2007 | 1525 | 0.070 |
Why?
|
| DNA Glycosylases | 1 | 2007 | 88 | 0.070 |
Why?
|
| Genome-Wide Association Study | 2 | 2012 | 2351 | 0.070 |
Why?
|
| Humans | 14 | 2013 | 270740 | 0.070 |
Why?
|
| Energy Metabolism | 1 | 2012 | 997 | 0.070 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2006 | 603 | 0.070 |
Why?
|
| Age of Onset | 1 | 2008 | 853 | 0.070 |
Why?
|
| Databases, Nucleic Acid | 1 | 2006 | 116 | 0.070 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2010 | 1126 | 0.060 |
Why?
|
| Mutation | 3 | 2010 | 15912 | 0.060 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 3597 | 0.060 |
Why?
|
| Diet | 1 | 2012 | 1477 | 0.060 |
Why?
|
| Cell Adhesion Molecules | 1 | 2006 | 572 | 0.060 |
Why?
|
| Phenotype | 2 | 2012 | 6509 | 0.060 |
Why?
|
| Base Sequence | 1 | 2010 | 5437 | 0.050 |
Why?
|
| Oxidative Stress | 1 | 2009 | 1149 | 0.050 |
Why?
|
| Molecular Sequence Data | 1 | 2010 | 6685 | 0.050 |
Why?
|
| Aged, 80 and over | 4 | 2012 | 30998 | 0.050 |
Why?
|
| Gene Expression Regulation | 1 | 2012 | 4130 | 0.050 |
Why?
|
| Blotting, Western | 1 | 2006 | 3584 | 0.050 |
Why?
|
| DNA Repair | 1 | 2007 | 1909 | 0.040 |
Why?
|
| Age Factors | 1 | 2008 | 5457 | 0.040 |
Why?
|
| Risk | 2 | 2013 | 1939 | 0.040 |
Why?
|
| Cells, Cultured | 1 | 2006 | 5694 | 0.040 |
Why?
|
| Cohort Studies | 1 | 2010 | 9470 | 0.040 |
Why?
|
| Cell Cycle Proteins | 1 | 2006 | 2115 | 0.040 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2012 | 9042 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2006 | 6177 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2006 | 7655 | 0.030 |
Why?
|
| Male | 4 | 2009 | 128315 | 0.030 |
Why?
|
| Survival Rate | 1 | 2007 | 12541 | 0.030 |
Why?
|
| MutL Protein Homolog 1 | 1 | 2012 | 206 | 0.030 |
Why?
|
| Linkage Disequilibrium | 1 | 2013 | 494 | 0.030 |
Why?
|
| Gene Frequency | 1 | 2013 | 1246 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2012 | 1075 | 0.020 |
Why?
|
| Early Diagnosis | 1 | 2010 | 313 | 0.020 |
Why?
|
| Genetic Association Studies | 1 | 2013 | 1099 | 0.020 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2012 | 1199 | 0.020 |
Why?
|
| Lymphocytes | 1 | 2012 | 1275 | 0.020 |
Why?
|
| Blood Glucose | 1 | 2012 | 1269 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2012 | 2090 | 0.020 |
Why?
|
| Apurinic Acid | 1 | 2006 | 5 | 0.020 |
Why?
|
| Polynucleotides | 1 | 2006 | 14 | 0.020 |
Why?
|
| Alleles | 1 | 2012 | 2600 | 0.020 |
Why?
|
| Receptors, Estrogen | 1 | 2013 | 2170 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2012 | 2422 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2012 | 1470 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2010 | 3476 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2007 | 39890 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2012 | 6390 | 0.010 |
Why?
|
| Nuclear Proteins | 1 | 2012 | 3438 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2006 | 5101 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2006 | 6256 | 0.010 |
Why?
|